锦欣生殖(01951)于2026年3月30日公告，公司当日于香港联交所场内回购833,500股普通股，占已发行股本约0.03%，每股回购价介乎2.30港元至2.33港元，合共涉资约192.98万港元。该批回购股份拟注销但尚未注销。
公告显示，截至2026年3月30日，公司已发行股本(不包括库存股份)为2,744,706,043股，库存股份为13,000,000股。回购授权决议于2025年6月26日获通过，授权总数为274,470,604股，公司至今已在香港联交所或其他证券交易所累计回购44,013,000股，占授权通过当日已发行股本约1.6036%。
公司确认，本次回购行为符合香港联合交易所有限公司证券上市规则等相关法例的规定。公告由董事董阳签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.